Goldfinch Bio

Last updated: May 06, 2024

Anthony Johnson, CEO
Anthony Johnson, CEO
Country: USA | Funding: $210M (+)

Website: https://www.goldfinchbio.com

Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease.